Total Equity - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.15 CNY -3.17% Market Closed
Market Cap: 3.8B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Novogene Co Ltd
Total Equity Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Total Equity
ÂĄ2.5B
CAGR 3-Years
30%
CAGR 5-Years
20%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Total Equity
ÂĄ54.7B
CAGR 3-Years
14%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Total Equity
ÂĄ13B
CAGR 3-Years
12%
CAGR 5-Years
36%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Total Equity
ÂĄ40.7B
CAGR 3-Years
7%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Total Equity
ÂĄ20.8B
CAGR 3-Years
7%
CAGR 5-Years
41%
CAGR 10-Years
39%
Genscript Biotech Corp
HKEX:1548
Total Equity
$1.4B
CAGR 3-Years
11%
CAGR 5-Years
25%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Total Equity?
Total Equity
2.5B CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Total Equity amounts to 2.5B CNY.

What is Novogene Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
20%

Over the last year, the Total Equity growth was 25%. The average annual Total Equity growth rates for Novogene Co Ltd have been 30% over the past three years , 20% over the past five years .

Back to Top